These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 24708595)
41. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis. Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618 [TBL] [Abstract][Full Text] [Related]
42. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638 [TBL] [Abstract][Full Text] [Related]
43. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps. Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916 [TBL] [Abstract][Full Text] [Related]
44. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Bai AH; Tong JH; To KF; Chan MW; Man EP; Lo KW; Lee JF; Sung JJ; Leung WK Int J Cancer; 2004 Dec; 112(5):846-53. PubMed ID: 15386372 [TBL] [Abstract][Full Text] [Related]
45. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients. Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272 [TBL] [Abstract][Full Text] [Related]
46. Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population. Sinha R; Hussain S; Mehrotra R; Kumar RS; Kumar K; Pande P; Doval DC; Basir SF; Bharadwaj M PLoS One; 2013; 8(4):e60142. PubMed ID: 23573237 [TBL] [Abstract][Full Text] [Related]
47. The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor? Dhont L; Mascaux C; Belayew A Cell Mol Life Sci; 2016 Jan; 73(1):129-47. PubMed ID: 26472339 [TBL] [Abstract][Full Text] [Related]
48. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups. Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750 [TBL] [Abstract][Full Text] [Related]
49. Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. Gonzalo V; Lozano JJ; Muñoz J; Balaguer F; Pellisé M; Rodríguez de Miguel C; Andreu M; Jover R; Llor X; Giráldez MD; Ocaña T; Serradesanferm A; Alonso-Espinaco V; Jimeno M; Cuatrecasas M; Sendino O; Castellví-Bel S; Castells A; PLoS One; 2010 Jan; 5(1):e8777. PubMed ID: 20098741 [TBL] [Abstract][Full Text] [Related]
50. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma. Kumar A; Gosipatala SB; Pandey A; Singh P Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064 [TBL] [Abstract][Full Text] [Related]
51. HLTF suppresses the migration and invasion of colorectal cancer cells via TGF‑β/SMAD signaling in vitro. Liu L; Liu H; Zhou Y; He J; Liu Q; Wang J; Zeng M; Yuan D; Tan F; Zhou Y; Pei H; Zhu H Int J Oncol; 2018 Dec; 53(6):2780-2788. PubMed ID: 30320371 [TBL] [Abstract][Full Text] [Related]
52. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients. Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076 [TBL] [Abstract][Full Text] [Related]
53. Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancer. Xiang J; Zhou L; Zhuang Y; Zhang J; Sun Y; Li S; Zhang Z; Zhang G; He Y Oncol Rep; 2018 Nov; 40(5):2788-2797. PubMed ID: 30132561 [TBL] [Abstract][Full Text] [Related]
56. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection. Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744 [TBL] [Abstract][Full Text] [Related]
57. DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients. Nilsson TK; Löf-Öhlin ZM; Sun XF Int J Oncol; 2013 Jan; 42(1):127-33. PubMed ID: 23128528 [TBL] [Abstract][Full Text] [Related]
58. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan. Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582 [TBL] [Abstract][Full Text] [Related]
59. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. Pedersen SK; Symonds EL; Baker RT; Murray DH; McEvoy A; Van Doorn SC; Mundt MW; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Dekker E; Young GP BMC Cancer; 2015 Oct; 15():654. PubMed ID: 26445409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]